|
[1]
|
Geertsma, E.R., Chang, Y., Shaik, F.R., Neldner, Y., Pardon, E., Steyaert, J., et al. (2015) Structure of a Prokaryotic Fumarate Transporter Reveals the Architecture of the SLC26 Family. Nature Structural & Molecular Biology, 22, 803-808. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Lohi, H., Lamprecht, G., Markovich, D., Heil, A., Kujala, M., Seidler, U., et al. (2003) Isoforms of SLC26A6 Mediate Anion Transport and Have Functional PDZ Interaction Domains. American Journal of Physiology-Cell Physiology, 284, C769-C779. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Xie, Q., Welch, R., Mercado, A., Romero, M.F. and Mount, D.B. (2002) Molecular Characterization of the Murine Slc26a6 Anion Exchanger: Functional Comparison with Slc26a1. American Journal of Physiology-Renal Physiology, 283, F826-F838. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Huang, Y., Zhang, Y.H., Chi, Z.P., Huang, R., Huang, H., Liu, G., et al. (2019) The Handling of Oxalate in the Body and the Origin of Oxalate in Calcium Oxalate Stones. Urologia Internationalis, 104, 167-176. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kleta, R. (2006) A Key Stone Cop Regulates Oxalate Homeostasis. Nature Genetics, 38, 403-404. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Chernova, M.N., Jiang, L., Friedman, D.J., Darman, R.B., Lohi, H., Kere, J., et al. (2005) Functional Comparison of Mouse Slc26a6 Anion Exchanger with Human SLC26A6 Polypeptide Variants: Differences in Anion Selectivity, Regulation, and Electrogenicity. Journal of Biological Chemistry, 280, 8564-8580. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Knauf, F., Yang, C., Thomson, R.B., Mentone, S.A., Giebisch, G. and Aronson, P.S. (2001) Identification of a Chloride-Formate Exchanger Expressed on the Brush Border Membrane of Renal Proximal Tubule Cells. Proceedings of the National Academy of Sciences, 98, 9425-9430. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Osswald, H. and Hautmann, R. (1979) Renal Elimination Kinetics and Plasma Half-Life of Oxalate in Man. Urologia Internationalis, 34, 440-450. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Hatch, M., Freel, R.W. and Vaziri, N.D. (1994) Intestinal Excretion of Oxalate in Chronic Renal Failure. Journal of the American Society of Nephrology, 5, 1339-1343. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Hatch, M. and Freel, R.W. (2003) Angiotensin II Involvement in Adaptive Enteric Oxalate Excretion in Rats with Chronic Renal Failure Induced by Hyperoxaluria. Urological Research, 31, 426-432. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wang, Z., Petrovic, S., Mann, E. and Soleimani, M. (2002) Identification of an Apical Cl(-)/HCO3(-) Exchanger in the Small Intestine. American Journal of Physiology-Gastrointestinal and Liver Physiology, 282, G573-G579. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Jiang, Z., Asplin, J.R., Evan, A.P., Rajendran, V.M., Velazquez, H., Nottoli, T.P., et al. (2006) Calcium Oxalate Urolithiasis in Mice Lacking Anion Transporter Slc26a6. Nature Genetics, 38, 474-478. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Shtukenberg, A.G., Hu, L., Sahota, A., Kahr, B. and Ward, M.D. (2022) Disrupting Crystal Growth through Molecular Recognition: Designer Therapies for Kidney Stone Prevention. Accounts of Chemical Research, 55, 516-525. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Robertson, W.G. and Peacock, M. (1980) The Cause of Idiopathic Calcium Stone Disease: Hypercalciuria or Hyperoxaluria? Nephron, 26, 105-110. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Ogawa, Y., Miyazato, T. and Hatano, T. (2000) Oxalate and Urinary Stones. World Journal of Surgery, 24, 1154-1159. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Freel, R.W., Hatch, M., Green, M. and Soleimani, M. (2006) Ileal Oxalate Absorption and Urinary Oxalate Excretion Are Enhanced in Slc26a6 Null Mice. American Journal of Physiology-Gastrointestinal and Liver Physiology, 290, G719-G728. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Marengo, S.R. and Romani, A.M. (2008) Oxalate in Renal Stone Disease: The Terminal Metabolite That Just Won’t Go Away. Nature Clinical Practice Nephrology, 4, 368-377. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Holmes, R.P., Ambrosius, W.T. and Assimos, D.G. (2005) Dietary Oxalate Loads and Renal Oxalate Handling. Journal of Urology, 174, 943-947. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Greger, R., Lang, F., Oberleithner, H. and Deetjen, P. (1978) Handling of Oxalate by the Rat Kidney. Pflügers Archiv European Journal of Physiology, 374, 243-248. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Wang, T., Egbert, A.L., Abbiati, T., Aronson, P.S. and Giebisch, G. (1996) Mechanisms of Stimulation of Proximal Tubule Chloride Transport by Formate and Oxalate. American Journal of Physiology-Renal Physiology, 271, F446-F450. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Wang, T., Giebisch, G. and Aronson, P.S. (1992) Effects of Formate and Oxalate on Volume Absorption in Rat Proximal Tubule. American Journal of Physiology-Renal Physiology, 263, F37-F42. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Chen, T., Qian, B., Zou, J., Luo, P., Zou, J., Li, W., et al. (2023) Oxalate as a Potent Promoter of Kidney Stone Formation. Frontiers in Medicine, 10, Article ID: 1159616. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Cornière, N., Thomson, R.B., Thauvin, S., Villoutreix, B.O., Karp, S., Dynia, D.W., et al. (2022) Dominant Negative Mutation in Oxalate Transporter slc26a6 Associated with Enteric Hyperoxaluria and Nephrolithiasis. Journal of Medical Genetics, 59, 1035-1043. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Noonin, C. and Thongboonkerd, V. (2024) Beneficial Roles of Gastrointestinal and Urinary Microbiomes in Kidney Stone Prevention via Their Oxalate-Degrading Ability and Beyond. Microbiological Research, 282, Article 127663. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Al, K.F., Joris, B.R., Daisley, B.A., Chmiel, J.A., Bjazevic, J., Reid, G., et al. (2023) Multi-Site Microbiota Alteration Is a Hallmark of Kidney Stone Formation. Microbiome, 11, Article No. 263. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Zhang, R., Zhao, W., Zhao, R., Zhao, Y., Zhang, Y. and Liang, X. (2023) Causal Relationship in Gut Microbiota and Upper Urinary Urolithiasis Using Mendelian Randomization. Frontiers in Microbiology, 14, Article ID: 1170793. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Arvans, D., Jung, Y., Antonopoulos, D., Koval, J., Granja, I., Bashir, M., et al. (2016) Oxalobacter Formigenes—Derived Bioactive Factors Stimulate Oxalate Transport by Intestinal Epithelial Cells. Journal of the American Society of Nephrology, 28, 876-887. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Arvans, D., Chang, C., Alshaikh, A., Tesar, C., Babnigg, G., Wolfgeher, D., et al. (2023) Sel1-Like Proteins and Peptides Are the Major oxalobacter Formigenes-Derived Factors Stimulating Oxalate Transport by Human Intestinal Epithelial Cells. American Journal of Physiology-Cell Physiology, 325, C344-C361. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Mittl, P.R.E. and Schneider-Brachert, W. (2007) Sel1-Like Repeat Proteins in Signal Transduction. Cellular Signalling, 19, 20-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Ko, S.B.H., Zeng, W., Dorwart, M.R., Luo, X., Kim, K.H., Millen, L., et al. (2004) Gating of CFTR by the STAS Domain of SLC26 Transporters. Nature Cell Biology, 6, 343-350. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Ko, S.B.H., Shcheynikov, N., Choi, J.Y., Luo, X., Ishibashi, K., Thomas, P.J., Kim, J.Y., et al. (2002) A Molecular Mechanism for Aberrantcftr-Dependent HCO(3)(-)Transport in Cystic Fibrosis. The EMBO Journal, 21, 5662-5672. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Knauf, F., Thomson, R.B., Heneghan, J.F., Jiang, Z., Adebamiro, A., Thomson, C.L., et al. (2016) Loss of Cystic Fibrosis Transmembrane Regulator Impairs Intestinal Oxalate Secretion. Journal of the American Society of Nephrology, 28, 242-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Liu, Y., Jin, X., Hong, H.G., Xiang, L., Jiang, Q., Ma, Y., et al. (2020) The Relationship between Gut Microbiota and Short Chain Fatty Acids in the Renal Calcium Oxalate Stones Disease. The FASEB Journal, 34, 11200-11214. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Liu, Y., Jin, X., Ma, Y., Jian, Z., Wei, Z., Xiang, L., et al. (2021) Short-Chain Fatty Acids Reduced Renal Calcium Oxalate Stones by Regulating the Expression of Intestinal Oxalate Transporter Slc26a6. mSystems, 6, e0104521. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Jin, X., Jian, Z., Chen, X., Ma, Y., Ma, H., Liu, Y., et al. (2021) Short Chain Fatty Acids Prevent Glyoxylate-Induced Calcium Oxalate Stones by GPR43-Dependent Immunomodulatory Mechanism. Frontiers in Immunology, 12, Article ID: 729382. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Zhao, Z., Mai, Z., Ou, L., Duan, X. and Zeng, G. (2013) Serum Estradiol and Testosterone Levels in Kidney Stones Disease with and without Calcium Oxalate Components in Naturally Postmenopausal Women. PLOS ONE, 8, e75513. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Lee, D., Lee, P.C., Hong, J.H. and Shin, D.M. (2022) Estrogen Treatment Reduced Oxalate Transporting Activity and Enhanced Migration through the Involvement of SLC26A6 in Lung Cancer Cells. Toxicology in Vitro, 82, Article 105373. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Bhasin, B., Ürekli, H.M. and Atta, M.G. (2015) Primary and Secondary Hyperoxaluria: Understanding the Enigma. World Journal of Nephrology, 4, 235-244. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Holmes, R.P. and Kennedy, M. (2000) Estimation of the Oxalate Content of Foods and Daily Oxalate Intake. Kidney International, 57, 1662-1667. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Baker, P.R.S., Cramer, S.D., Kennedy, M., Assimos, D.G. and Holmes, R.P. (2004) Glycolate and Glyoxylate Metabolism in HepG2 Cells. American Journal of Physiology-Cell Physiology, 287, C1359-C1365. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Behnam, J.T., Williams, E.L., Brink, S., Rumsby, G. and Danpure, C.J. (2006) Reconstruction of Human Hepatocyte Glyoxylate Metabolic Pathways in Stably Transformed Chinese-Hamster Ovary Cells. Biochemical Journal, 394, 409-416. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Zhu, W., Zhao, Z., Chou, F., Zuo, L., Liu, T., Bushinsky, D., et al. (2019) The Protective Roles of Estrogen Receptor β in Renal Calcium Oxalate Crystal Formation via Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury. Oxidative Medicine and Cellular Longevity, 2019, Article ID: 5305014. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Tarhuni, M., Fotso, M.N., Gonzalez, N.A., Sanivarapu, R.R., Osman, U., Latha Kumar, A., et al. (2023) Estrogen’s Tissue-Specific Regulation of the SLC26A6 Anion Transporter Reveal a Phenotype of Kidney Stone Disease in Estrogen-Deficient Females: A Systematic Review. Cureus, 15, e45839. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Cil, O., Haggie, P.M., Tan, J.T., Rivera, A.A. and Verkman, A.S. (2021) SLC26A6-Selective Inhibitor Identified in a Small-Molecule Screen Blocks Fluid Absorption in Small Intestine. JCI Insight, 6, e147699. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Chu, T., Karmakar, J., Haggie, P.M., Tan, J., Master, R., Ramaswamy, K., et al. (2023) Selective Isoxazolopyrimidine PAT1 (SLC26A6) Inhibitors for Therapy of Intestinal Disorders. RSC Medicinal Chemistry, 14, 2342-2347. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Knauf, F., Ko, N., Jiang, Z., Robertson, W.G., Van Itallie, C.M., Anderson, J.M., et al. (2011) Net Intestinal Transport of Oxalate Reflects Passive Absorption and SLC26A6-Mediated Secretion. Journal of the American Society of Nephrology, 22, 2247-2255. [Google Scholar] [CrossRef] [PubMed]
|